Update on bladder cancer molecular subtypes
نویسندگان
چکیده
منابع مشابه
Molecular subtypes of bladder cancer :
Cancer of the bladder shows divergent clinical behaviour following diagnosis and it has been proposed that 2 major groups of tumours exist that develop via different molecular pathways. Low-grade, non-invasive papillary tumours recur frequently, but patients with these tumours do not often suffer progression of disease to muscle invasion. In contrast, tumours that are invading muscle at diagnos...
متن کاملConsensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications
The colorectal cancer (CRC) subtyping consortium has unified six independent molecular classification systems, based on gene expression data, into a single consensus system with four distinct groups, known as the consensus molecular subtypes (CMS); clinical implications are discussed in this review based on articles relevant to the CMS of CRC indexed in PubMed as well as the authors’ own ...
متن کاملConsensus on Molecular Subtypes of Ovarian Cancer
INTRODUCTION: Various computational methods for gene expression-based subtyping of highgrade serous (HGS) ovarian cancer have been proposed. This resulted in the identification of molecular subtypes that are based on different datasets and were differentially validated, making it difficult to achieve consensus on which definitions to use in follow-up studies. We assess three major subtype class...
متن کاملIntrinsic subtypes and bladder cancer metastasis
Recent studies demonstrated that bladder cancers can be grouped into basal and luminal molecular subtypes that possess distinct biological and clinical characteristics. Basal bladder cancers express biomarkers characteristic of cancer stem cells and epithelial-to-mesenchymal transition (EMT). Patients with basal cancers tend have more advanced stage and metastatic disease at presentation. In pr...
متن کاملUnderstanding lung cancer molecular subtypes
• Histological examination of a tissue biopsy is required to differentiate between different lung cancer histiotypes. • In non-small-cell lung cancer, judicious use of a limited immunohistochemistry panel is recommended to differentiate between squamous cell and adenocarcinoma, and maximize tumor material for molecular analyses. • Clinical selection criteria should not be used to select patient...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Translational Andrology and Urology
سال: 2020
ISSN: 2223-4683,2223-4691
DOI: 10.21037/tau-2019-mibc-12